curasan AG

euro adhoc: curasan AG
Restructuring & Recapitalisations
curasan AG: increase in capital

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc.   The issuer is responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@

09.11.2005

Kleinostheim, November 9, 2005 - Today, curasan AG (ISIN DE 000 549 453 8) listed in the Prime Standard, has placed 500,000 new ordinary shares, in the form of bearer shares, as a capital increase. This capital increase was submitted to the Supervisory Board on November 8 for approval and authorization on the same day. The capital increase of EUR 500,000, from currently EUR 5,250,000 to EUR 5,750,000, was executed within the framework of existing Authorised Capital (so-called "Genehmigtes Kapital").

The shares offered in this private placement round were exclusively subscribed by institutional investors. The subscription right of shareholders does not apply. The issue price of the new shares is EUR 2.60 per share. The new shares have a dividend right, effective January 1, 2005.

The proceeds from this offering will primarily be used for a new product line which will be introduced by curasan AG shortly.

end of ad hoc release

About curasan AG: curasan AG (ISIN: DE 000 549 453 8), an exchange-listed company, is a leading innovator within the growth market of bone and tissue regeneration. The company has developed a comprehensive product range centred around its synthetic bone regeneration material Cerasorb®, for use in soft and hard tissue. curasan AG's main goal is to occupy a leading position as a global specialist in Regenerative Medicine. For further information, please visit curasan’s corporate website at: www.curasan.de

@@start.t2@@end of announcement                                                 euro adhoc 09.11.2005 13:58:38
--------------------------------------------------------------------------------@@end@@

ots Originaltext: curasan AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:
Dr. Erwin Amashaufer
Tel.: +49(0)6027-4686-465
E-Mail: ir@curasan.de

Branche: Biotechnology
ISIN:      DE0005494538
WKN:        549453
Index:    CDAX, Classic All Share, Prime All Share
Börsen:  Frankfurter Wertpapierbörse / regulated dealing/prime
              standard
              Berliner Wertpapierbörse / free trade
              Hamburger Wertpapierbörse / free trade
              Baden-Württembergische Wertpapierbörse / free trade
              Börse Düsseldorf / free trade
              Niedersächsische Börse zu Hannover / free trade
              Bayerische Börse / free trade
              Bremer Wertpapierbörse (BWB) / free trade



Weitere Meldungen: curasan AG

Das könnte Sie auch interessieren: